These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 680386)
1. Serovaccination by human immune globulin and HDCS-vaccine against rabies. Kuwert EK; Werner J; Marcus I; Cabasso VJ Dev Biol Stand; 1978; 40():129-36. PubMed ID: 680386 [TBL] [Abstract][Full Text] [Related]
2. Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man. Nicholson KG; Turner GS Dev Biol Stand; 1978; 40():115-20. PubMed ID: 680384 [TBL] [Abstract][Full Text] [Related]
3. Humoral immunity conferred by the HDCS rabies vaccine Mérieux administered after exposure: 151 cases with and without specific immune globulin of human origin. Preliminary communication. Méan F; Steck F; Tanner F Dev Biol Stand; 1978; 40():159-61. PubMed ID: 680389 [TBL] [Abstract][Full Text] [Related]
4. Some experiences with human diploid cell strain-(HDCS) rabies vaccine in pre- and post-exposure vaccinated humans. Kuwert EK; Marcus I; Werner J; Iwand A; Thraenhart O Dev Biol Stand; 1978; 40():79-88. PubMed ID: 680404 [TBL] [Abstract][Full Text] [Related]
5. Post-exposure use of human diploid cell culture rabies vaccine. Kuwert EK; Marcus I; Werner J; Scheiermann N; Höher PG; Thraenhart O; Hierholzer E; Wiktor TJ; Koprowski H Dev Biol Stand; 1976 Dec 13-15; 37():273-86. PubMed ID: 1031689 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine. Deshpande AK; Londhe VA; Akarte S; Briggs D J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031 [TBL] [Abstract][Full Text] [Related]
8. Human rabies globulin and human diploid vaccine dose determinations. Hafkin B; Alls ME; Baer GM Dev Biol Stand; 1978; 40():121-7. PubMed ID: 680385 [TBL] [Abstract][Full Text] [Related]
9. Human rabies immunoprophylaxis using HDC (MRC-5) vaccine. Cox JH; Klietmann W; Schneider LG Dev Biol Stand; 1978; 40():105-8. PubMed ID: 680382 [TBL] [Abstract][Full Text] [Related]
10. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group. Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840 [TBL] [Abstract][Full Text] [Related]
11. Rabies post-exposure treatment and side-effects in man using HDC (MRC 5) vaccine. Klietmann W; Domres B; Cox JH Dev Biol Stand; 1978; 40():109-13. PubMed ID: 567152 [TBL] [Abstract][Full Text] [Related]
12. Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects. Cabasso VJ; Loofbourow JC; Roby RE; Anuskiewicz W Bull World Health Organ; 1971; 45(3):303-15. PubMed ID: 5316911 [TBL] [Abstract][Full Text] [Related]
13. Serological investigations on rabies tissue culture vaccine (USSR) and development of short methods in post-exposure treatment. Sinnecker H; Apitzsch L; Sinnecker R; Selimov M; Giard W; Grimm J; Mueller B; Rasch G; Zilske E Dev Biol Stand; 1978; 40():155-8. PubMed ID: 680388 [TBL] [Abstract][Full Text] [Related]
15. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
16. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals]. Baysal B; Tosun S; Ozdemir M; Doğan M Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389 [TBL] [Abstract][Full Text] [Related]
17. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4. Atanasiu P; Dean DJ; Habel K; Kaplan MM; Koprowski H; Lépine P; Serié C Bull World Health Organ; 1967; 36(3):361-5. PubMed ID: 5299668 [TBL] [Abstract][Full Text] [Related]
18. Treatment of patients bitten by rabid or suspected rabid wolves with inactivated tissue culture rabies vaccine and rabies gammaglobulin. Selimov MA; Klyueva EV; Aksenova TA; Lebedeva IR; Gribencha LF Dev Biol Stand; 1978; 40():141-6. PubMed ID: 79511 [TBL] [Abstract][Full Text] [Related]
19. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642 [TBL] [Abstract][Full Text] [Related]
20. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule]. Landry P; Lazzaro M; Darioli R Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]